Chronic Lymphocytic Leukemia (CLL) in the Community Setting
In this 4-part series on chronic lymphocytic leukemia (CLL), hear from expert clinicians, Dr. Danielle Brander, Dr. Nilanjan Ghosh, Dr. Matthew Davids and Dr. Nicole Lamanna, as they explore current data and the patient and care-team factors that influence selection of therapy for CLL in the community setting. An in-depth analysis of community-based CLL practice patterns, registry data, and clinical guidelines can provide a benchmark for your own practice. Does your practice align with current evidence?
These activities are jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with CLL Society.
Series Courses
![Gettyimages 488214462](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/gettyimages-488214462.jpg 496w)
Cytogenetic Testing for Patients with CLL/SLL
CME: 0.5
View Course
![Screenshot 2024 03 08 110832](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/screenshot_2024-03-08_110832.jpg 496w)
Chronic Lymphocytic Leukemia: Guideline Recommendations for the Front-line Setting
CME: 0.5
View Course
![Image patient cll](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/image.patient.cll.jpg 496w)
Patient Priorities for CLL Care
CME: 0.5
View Course
![Gettyimages 640023010 1](https://prodcraftsa01.blob.core.windows.net/assets/products/_496x244_crop_top-center_none/gettyimages-640023010_1.jpg 496w)
Chronic Lymphocytic Leukemia: Guideline Recommendations for the Relapsed/Refractory Setting
CME: 0.5
View Course